Literature DB >> 22793940

Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.

Carlos H Martinez1, MeiLan K Han.   

Abstract

* COPD is a heterogeneous disease, modified by environmental and intrinsic host factors. The interaction between COPD and its comorbidities is complex and bidirectional. * It has been estimated that the proportion of patients with COPD caused by cigarette smoking is between 80% and 90%. Risk factors associated with COPD in nonsmokers are numerous and incompletely understood, but a history of asthma or tuberculosis, exposure to traffic and outdoor pollution, and exposure to biomass smoke show the strongest associations. Other factors that may contribute to COPD phenotypes include gender, genetics, and the lung microbiome. * Certain comorbid conditions, such as cardiovascular disease and osteoporosis, are more common in the COPD patient population. Other comorbidities, such as overlap syndrome, the coexistence of COPD, and obstructive sleep apnea may not be as prevalent in COPD but are important because they may modify disease course. * Systemic inflammation may be pathogenically related to many comorbidities seen in COPD including cardiovascular disease, osteoporosis, metabolic syndrome, and depression. * Based on the data presented here, two general patterns of clinical features and comorbidities that share some associations are (1) emphysema, low BMI and osteoporosis and (2) chronic bronchitis, airway disease, high BMI, OSA, and diabetes. * The classification of patients with COPD into subgroups with shared characteristics and outcomes offers the potential for specific interventions. New research tools from the fields of epidemiology, immunology, imaging, and data analysis will be helpful in accomplishing this goal.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22793940      PMCID: PMC4629222          DOI: 10.1016/j.mcna.2012.02.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  105 in total

1.  Do vegetables and fruits reduce the risk of chronic obstructive pulmonary disease? A case-control study in Japan.

Authors:  Fumi Hirayama; Andy H Lee; Colin W Binns; Yun Zhao; Tetsuo Hiramatsu; Yoshimasa Tanikawa; Koichi Nishimura; Hiroyuki Taniguchi
Journal:  Prev Med       Date:  2009-06-23       Impact factor: 4.018

2.  Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.

Authors:  Matthias John; Andre Lange; Soeren Hoernig; Christian Witt; Stefan D Anker
Journal:  Int J Cardiol       Date:  2005-10-19       Impact factor: 4.164

3.  Sex differences in severe pulmonary emphysema.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Frank Sciurba; Jeanette Mumford; Nicholas D Giardino; Gail Weinmann; Ella Kazerooni; Susan Murray; Gerard J Criner; Donald D Sin; James Hogg; Andrew L Ries; MeiLan Han; Alfred P Fishman; Barry Make; Eric A Hoffman; Zab Mohsenifar; Robert Wise
Journal:  Am J Respir Crit Care Med       Date:  2007-04-12       Impact factor: 21.405

4.  Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome).

Authors:  C Mermigkis; A Kopanakis; N Foldvary-Schaefer; J Golish; V Polychronopoulos; S Schiza; A Amfilochiou; N Siafakas; D Bouros
Journal:  Int J Clin Pract       Date:  2007-02       Impact factor: 2.503

Review 5.  Systemic effects of chronic obstructive pulmonary disease.

Authors:  A G N Agustí; A Noguera; J Sauleda; E Sala; J Pons; X Busquets
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

6.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

7.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

8.  Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Authors:  Peter M A Calverley; Klaus F Rabe; Udo-Michael Goehring; Søren Kristiansen; Leonardo M Fabbri; Fernando J Martinez
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

9.  Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease.

Authors:  Paul D Blanc; Mark D Eisner; Gillian Earnest; Laura Trupin; John R Balmes; Edward H Yelin; Steven E Gregorich; Patricia P Katz
Journal:  J Occup Environ Med       Date:  2009-07       Impact factor: 2.162

10.  Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.

Authors:  Philip M Short; Samuel I W Lipworth; Douglas H J Elder; Stuart Schembri; Brian J Lipworth
Journal:  BMJ       Date:  2011-05-10
View more
  15 in total

1.  Inflammasome Activity in Non-Microbial Lung Inflammation.

Authors:  Jennifer L Ather; Rebecca A Martin; Karina Ckless; Matthew E Poynter
Journal:  J Environ Immunol Toxicol       Date:  2014-09-20

2.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

3.  Occupational risk factors for COPD phenotypes in the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.

Authors:  Brent Doney; Eva Hnizdo; Monica Graziani; Greg Kullman; Cecil Burchfiel; Sherry Baron; Kaori Fujishiro; Paul Enright; John L Hankinson; Karen Hinckley Stukovsky; Christopher J Martin; Kathleen M Donohue; R Graham Barr
Journal:  COPD       Date:  2014-02-25       Impact factor: 2.409

4.  Socioeconomic Characteristics Are Major Contributors to Ethnic Differences in Health Status in Obstructive Lung Disease: An Analysis of the National Health and Nutrition Examination Survey 2007-2010.

Authors:  Carlos H Martinez; David M Mannino; Jeffrey L Curtis; MeiLan K Han; Alejandro A Diaz
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

Review 5.  Defining COPD-Related Comorbidities, 2004-2014.

Authors:  Carlos H Martinez; David M Mannino; Miguel J Divo
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

6.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

7.  The RESPECT study: RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocol.

Authors:  Elena Andreeva; Marina Pokhaznikova; Anatoly Lebedev; Irina Moiseeva; Anton Kozlov; Olga Kuznetsova; Jean-Marie Degryse
Journal:  BMC Public Health       Date:  2015-08-28       Impact factor: 3.295

8.  Chronic obstructive pulmonary disease, cognitive impairment, and development of disability: the health and retirement study.

Authors:  Carlos H Martinez; Caroline R Richardson; MeiLan K Han; Christine T Cigolle
Journal:  Ann Am Thorac Soc       Date:  2014-11

9.  Taking Healthy Steps: rationale, design and baseline characteristics of a randomized trial of a pedometer-based Internet-mediated walking program in veterans with chronic obstructive pulmonary disease.

Authors:  Carlos H Martinez; Marilyn L Moy; Huong Q Nguyen; Miriam Cohen; Reema Kadri; Pia Roman; Robert G Holleman; Hyungjin Myra Kim; David E Goodrich; Nicholas D Giardino; Caroline R Richardson
Journal:  BMC Pulm Med       Date:  2014-02-03       Impact factor: 3.317

10.  Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.

Authors:  Carlos H Martinez; Yuka Okajima; Susan Murray; George R Washko; Fernando J Martinez; Edwin K Silverman; Jin Hwa Lee; Elizabeth A Regan; James D Crapo; Jeffrey L Curtis; Hiroto Hatabu; MeiLan K Han
Journal:  Respir Res       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.